-
AAM-commissioned report: Biosimilars can save CMS $11.4B by 2027
WASHINGTON — A new report from the Moran Co. for the Association for Accessible Medicines and its Biosimilars Council is projecting big savings to the federal government from biosimilars in the next 10 years. But the estimated $11.4 billion in savings would require the Centers for Medicare and Medicaid Services to revise the way it currently reimburses for biosimilar drugs.
-
NACDS touts in-district RxImpact efforts
ALEXANDRIA, Va. — With Congress back from its August recess, the National Association of Chain Drug Stores has shared some data about the efforts it made to reach out to lawmakers in their district. The organization said that more than half of NACDS RxImpact 2017 activities allowed advocates access to legislators who support pharmacist provider status, and that almost 20% signed on to support the bill following the in-district efforts.